Počet záznamov: 1
syndróm antifosfolipidový
SYS d016736 LBL 00000cx--j2200000---45-- 005 20240119201309.7 100 $a 19920429asloy0103----ba0 152 $b mesh 250 $a syndróm antifosfolipidový $x BL $x CF $x CI $x CL $x CN $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SU $x TH $x UR $x VE $x VI $8 slo 300 1-
$a 92; PHOSPHOLIPID ANTIBODY SYNDROME was see ANTIPHOSPHOLIPID SYNDROME 1992 $8 eng 300 1-
$a Phospholipids/immunology (1977-1991) $8 eng 330 1-
$a The presence of antibodies directed against phospholipids (ANTIBODIES, ANTIPHOSPHOLIPID). The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies (ANTIBODIES, ANTICARDIOLIPIN). Present also are high levels of lupus anticoagulant (LUPUS COAGULATION INHIBITOR). $8 eng 450 $a Hughesov syndróm $5 e $8 slo 550 $3 sllk_un_auth*d002308 $Y Cardiolipins $5 B $a kardiolipíny 550 $3 sllk_un_auth*d008180 $Y Lupus Erythematosus, Systemic $5 B $a lupus erythematosus, systémový 550 $3 sllk_un_auth*d010743 $Y Phospholipids $5 B $a fosfolipidy 550 $3 sllk_un_auth*d016682 $Y Lupus Coagulation Inhibitor $5 B $a lupus antikoagulans 550 $3 sllk_un_auth*d017152 $Y Antibodies, Antiphospholipid $5 B $a protilátky antifosfolipidové 686 $a C20.111.197 750 $a Antiphospholipid Syndrome $8 eng 801 -0
$a US $b DNLM $c 19920429 801 -2
$a SK $b BA006 $c 20070706 801 -2
$a SK $b BA006 $c 20160211 980 $x M
Počet záznamov: 1